{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T20:07:16Z","timestamp":1776283636973,"version":"3.50.1"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T00:00:00Z","timestamp":1621296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T00:00:00Z","timestamp":1621296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Foundation La Caixa","award":["LCF\/PR\/HP17\/52190001"],"award-info":[{"award-number":["LCF\/PR\/HP17\/52190001"]}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["CENTRO-01-0145-FEDER-000008:BrainHealth 2020"],"award-info":[{"award-number":["CENTRO-01-0145-FEDER-000008:BrainHealth 2020"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["POCI-01-0145-FEDER-03127"],"award-info":[{"award-number":["POCI-01-0145-FEDER-03127"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The increased healthspan afforded by coffee intake provides novel opportunities to identify new therapeutic strategies. Caffeine has been proposed to afford benefits through adenosine A<jats:sub>2A<\/jats:sub> receptors, which can control synaptic dysfunction underlying some brain disease. However, decaffeinated coffee and other main components of coffee such as chlorogenic acids, also attenuate brain dysfunction, although it is unknown if they control synaptic function. We now used electrophysiological recordings in mouse hippocampal slices to test if realistic concentrations of chlorogenic acids directly affect synaptic transmission and plasticity. 3-(3,4-dihydroxycinnamoyl)quinic acid (CA, 1\u201310\u00a0\u03bcM) and 5-O-(trans-3,4-dihydroxycinnamoyl)-D-quinic acid (NCA, 1\u201310\u00a0\u03bcM) were devoid of effect on synaptic transmission, paired-pulse facilitation or long-term potentiation (LTP) and long-term depression (LTD) in Schaffer collaterals-CA1 pyramidal synapses. However, CA and NCA increased the recovery of synaptic transmission upon re-oxygenation following 7\u00a0min of oxygen\/glucose deprivation, an in vitro ischemia model. Also, CA and NCA attenuated the shift of LTD into LTP observed in hippocampal slices from animals with hippocampal-dependent memory deterioration after exposure to \u03b2-amyloid 1\u201342 (2\u00a0nmol, icv), in the context of Alzheimer\u2019s disease. These findings show that chlorogenic acids do not directly affect synaptic transmission and plasticity but can indirectly affect other cellular targets to correct synaptic dysfunction. Unraveling the molecular mechanisms of action of chlorogenic acids will allow the design of hitherto unrecognized novel neuroprotective strategies.<\/jats:p>","DOI":"10.1038\/s41598-021-89964-0","type":"journal-article","created":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T10:06:23Z","timestamp":1621332383000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Neuromodulation and neuroprotective effects of chlorogenic acids in excitatory synapses of mouse hippocampal slices"],"prefix":"10.1038","volume":"11","author":[{"given":"Mara Yone D.","family":"Fernandes","sequence":"first","affiliation":[]},{"given":"Fernando","family":"Dobrachinski","sequence":"additional","affiliation":[]},{"given":"Henrique B.","family":"Silva","sequence":"additional","affiliation":[]},{"given":"Jo\u00e3o Pedro","family":"Lopes","sequence":"additional","affiliation":[]},{"given":"Francisco Q.","family":"Gon\u00e7alves","sequence":"additional","affiliation":[]},{"given":"Felix A. A.","family":"Soares","sequence":"additional","affiliation":[]},{"given":"Lisiane O.","family":"Porci\u00fancula","sequence":"additional","affiliation":[]},{"given":"Geanne M.","family":"Andrade","sequence":"additional","affiliation":[]},{"given":"Rodrigo A.","family":"Cunha","sequence":"additional","affiliation":[]},{"given":"Angelo R.","family":"Tom\u00e9","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2021,5,18]]},"reference":[{"key":"89964_CR1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-nutr-071816-064941","author":"G Grosso","year":"2017","unstructured":"Grosso, G., Godos, J., Galvano, F. & Giovannucci, E. L. Coffee, caffeine, and health outcomes: an umbrella review. Annu. Rev. Nutr. https:\/\/doi.org\/10.1146\/annurev-nutr-071816-064941 (2017).","journal-title":"Annu. Rev. Nutr."},{"key":"89964_CR2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j5024","author":"R Poole","year":"2017","unstructured":"Poole, R. et al. Coffee consumption and health: Umbrella review of meta-analyses of multiple health outcomes. BMJ https:\/\/doi.org\/10.1136\/bmj.j5024 (2017).","journal-title":"BMJ"},{"key":"89964_CR3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1816604","author":"RM Van Dam","year":"2020","unstructured":"Van Dam, R. M., Hu, F. B. & Willett, W. C. Coffee, caffeine, and health. N. Engl. J. Med. https:\/\/doi.org\/10.1056\/NEJMra1816604 (2020).","journal-title":"N. Engl. J. Med."},{"key":"89964_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-019-00524-3","author":"Y Kim","year":"2019","unstructured":"Kim, Y., Je, Y. & Giovannucci, E. Coffee consumption and all-cause and cause-specific mortality: a meta-analysis by potential modifiers. Eur. J. Epidemiol. https:\/\/doi.org\/10.1007\/s10654-019-00524-3 (2019).","journal-title":"Eur. J. Epidemiol."},{"key":"89964_CR5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2011.03590.x","author":"J Olesen","year":"2012","unstructured":"Olesen, J. et al. The economic cost of brain disorders in Europe. Eur. J. Neurol. https:\/\/doi.org\/10.1111\/j.1468-1331.2011.03590.x (2012).","journal-title":"Eur. J. Neurol."},{"key":"89964_CR6","doi-asserted-by":"publisher","DOI":"10.1017\/S1368980010000509","author":"A Ruusunen","year":"2010","unstructured":"Ruusunen, A. et al. Coffee, tea and caffeine intake and the risk of severe depression in middle-aged Finnish men: The Kuopio Ischaemic Heart Disease Risk Factor study. Public Health Nutr. https:\/\/doi.org\/10.1017\/S1368980010000509 (2010).","journal-title":"Public Health Nutr."},{"key":"89964_CR7","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2011.393","author":"M Lucas","year":"2011","unstructured":"Lucas, M. et al. Coffee, caffeine, and risk of depression among women. Arch. Intern. Med. https:\/\/doi.org\/10.1001\/archinternmed.2011.393 (2011).","journal-title":"Arch. Intern. Med."},{"key":"89964_CR8","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.201500620","author":"G Grosso","year":"2016","unstructured":"Grosso, G., Micek, A., Castellano, S., Pajak, A. & Galvano, F. Coffee, tea, caffeine and risk of depression: a systematic review and dose-response meta-analysis of observational studies. Mol. Nutr. Food Res. https:\/\/doi.org\/10.1002\/mnfr.201500620 (2016).","journal-title":"Mol. Nutr. Food Res."},{"key":"89964_CR9","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-2010-091387","author":"C Santos","year":"2010","unstructured":"Santos, C., Costa, J., Santos, J., Vaz-Carneiro, A. & Lunet, N. Caffeine intake and dementia: Systematic review and meta-analysis. J. Alzheimers Dis. https:\/\/doi.org\/10.3233\/JAD-2010-091387 (2010).","journal-title":"J. Alzheimers Dis."},{"key":"89964_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/nu10101501","author":"SC Larsson","year":"2018","unstructured":"Larsson, S. C. & Orsini, N. Coffee consumption and risk of dementia and Alzheimer\u2019s disease: a dose-response meta-analysis of prospective studies. Nutrients https:\/\/doi.org\/10.3390\/nu10101501 (2018).","journal-title":"Nutrients"},{"key":"89964_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/nu12030840","author":"X Dong","year":"2020","unstructured":"Dong, X., Li, S., Sun, J., Li, Y. & Zhang, D. Association of coffee, decaffeinated coffee and caffeine intake from coffee with cognitive performance in older adults: National Health and Nutrition Examination Survey (NHANES) 2011\u20132014. Nutrients https:\/\/doi.org\/10.3390\/nu12030840 (2020).","journal-title":"Nutrients"},{"key":"89964_CR12","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-2010-1408","author":"RA Cunha","year":"2010","unstructured":"Cunha, R. A. & Agostinho, P. M. Chronic caffeine consumption prevents memory disturbance in different animal models of memory decline. J. Alzheimers Dis. https:\/\/doi.org\/10.3233\/JAD-2010-1408 (2010).","journal-title":"J. Alzheimers Dis."},{"key":"89964_CR13","doi-asserted-by":"publisher","DOI":"10.1152\/physiolgenomics.90353.2008","author":"L Yu","year":"2009","unstructured":"Yu, L. et al. Uncovering multiple molecular targets for caffeine using a drug target validation strategy combining A2A receptor knockout mice with microarray profiling. Physiol. Genom. https:\/\/doi.org\/10.1152\/physiolgenomics.90353.2008 (2009).","journal-title":"Physiol. Genom."},{"key":"89964_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2019.06.008","author":"JP Lopes","year":"2019","unstructured":"Lopes, J. P., Pli\u00e1ssova, A. & Cunha, R. A. The physiological effects of caffeine on synaptic transmission and plasticity in the mouse hippocampus selectively depend on adenosine A1 and A2A receptors. Biochem. Pharmacol. https:\/\/doi.org\/10.1016\/j.bcp.2019.06.008 (2019).","journal-title":"Biochem. Pharmacol."},{"key":"89964_CR15","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.13724","author":"RA Cunha","year":"2016","unstructured":"Cunha, R. A. How does adenosine control neuronal dysfunction and neurodegeneration?. J. Neurochem. https:\/\/doi.org\/10.1111\/jnc.13724 (2016).","journal-title":"J. Neurochem."},{"key":"89964_CR16","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1423088112","author":"MP Kaster","year":"2015","unstructured":"Kaster, M. P. et al. Caffeine acts through neuronal adenosine A2A receptors to prevent mood and memory dysfunction triggered by chronic stress. Proc. Natl. Acad. Sci. USA https:\/\/doi.org\/10.1073\/pnas.1423088112 (2015).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"89964_CR17","doi-asserted-by":"publisher","unstructured":"Canas, P.M. et al. Neuronal adenosine A2A receptors are critical mediators of neurodegeneration triggered by convulsions. eNeuro. https:\/\/doi.org\/10.1523\/ENEURO.0385-18.2018 (2018).","DOI":"10.1523\/ENEURO.0385-18.2018"},{"key":"89964_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2019.104570","author":"FQ Gon\u00e7alves","year":"2019","unstructured":"Gon\u00e7alves, F. Q. et al. Synaptic and memory dysfunction in a \u03b2-amyloid model of early Alzheimer\u2019s disease depends on increased formation of ATP-derived extracellular adenosine. Neurobiol. Dis. https:\/\/doi.org\/10.1016\/j.nbd.2019.104570 (2019).","journal-title":"Neurobiol. Dis."},{"key":"89964_CR19","doi-asserted-by":"publisher","DOI":"10.1126\/science.1222939","author":"RS Duman","year":"2012","unstructured":"Duman, R. S. & Aghajanian, G. K. Synaptic dysfunction in depression: potential therapeutic targets. Science https:\/\/doi.org\/10.1126\/science.1222939 (2012).","journal-title":"Science"},{"key":"89964_CR20","doi-asserted-by":"publisher","DOI":"10.1126\/science.1074069","author":"DJ Selkoe","year":"2002","unstructured":"Selkoe, D. J. Alzheimer\u2019s disease is a synaptic failure. Science https:\/\/doi.org\/10.1126\/science.1074069 (2002).","journal-title":"Science"},{"key":"89964_CR21","doi-asserted-by":"publisher","DOI":"10.1021\/jf804025c","author":"Y Wang","year":"2009","unstructured":"Wang, Y. & Ho, C. T. Polyphenolic chemistry of tea and coffee: a century of progress. J. Agric. Food Chem. https:\/\/doi.org\/10.1021\/jf804025c (2009).","journal-title":"J. Agric. Food Chem."},{"key":"89964_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/bs.apha.2019.12.002","author":"M Miao","year":"2020","unstructured":"Miao, M. & Xiang, L. Pharmacological action and potential targets of chlorogenic acid. Adv. Pharmacol. https:\/\/doi.org\/10.1016\/bs.apha.2019.12.002 (2020).","journal-title":"Adv. Pharmacol."},{"key":"89964_CR23","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-011-2395-0","author":"V Cropley","year":"2012","unstructured":"Cropley, V. et al. Does coffee enriched with chlorogenic acids improve mood and cognition after acute administration in healthy elderly? A pilot study. Psychopharmacology https:\/\/doi.org\/10.1007\/s00213-011-2395-0 (2012).","journal-title":"Psychopharmacology"},{"key":"89964_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0082897","author":"DA Camfield","year":"2013","unstructured":"Camfield, D. A. et al. A randomised placebo-controlled trial to differentiate the acute cognitive and mood effects of chlorogenic acid from decaffeinated coffee. PLoS ONE https:\/\/doi.org\/10.1371\/journal.pone.0082897 (2013).","journal-title":"PLoS ONE"},{"key":"89964_CR25","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/8608497","author":"M Kato","year":"2018","unstructured":"Kato, M., Ochiai, R., Kozuma, K., Sato, H. & Katsuragi, Y. Effect of chlorogenic acid intake on cognitive function in the elderly: a pilot study. Evid. Based Complement. Alternat. Med. https:\/\/doi.org\/10.1155\/2018\/8608497 (2018).","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"89964_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/nu10101337","author":"K Saitou","year":"2018","unstructured":"Saitou, K. et al. Effect of chlorogenic acids on cognitive function: a randomized, double-blind, placebo-controlled trial. Nutrients https:\/\/doi.org\/10.3390\/nu10101337 (2018).","journal-title":"Nutrients"},{"key":"89964_CR27","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-190757","author":"R Ochiai","year":"2019","unstructured":"Ochiai, R., Saitou, K., Suzukamo, C., Osaki, N. & Asada, T. Effect of chlorogenic acids on cognitive function in mild cognitive impairment: a randomized controlled crossover trial. J. Alzheimers Dis. https:\/\/doi.org\/10.3233\/JAD-190757 (2019).","journal-title":"J. Alzheimers Dis."},{"key":"89964_CR28","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S235969","author":"L Gao","year":"2020","unstructured":"Gao, L. et al. Chlorogenic acid alleviates A\u03b225-35-induced autophagy and cognitive impairment via the mTOR\/TFEB signaling pathway. Drug Des. Devel. Ther. https:\/\/doi.org\/10.2147\/DDDT.S235969 (2020).","journal-title":"Drug Des. Devel. Ther."},{"key":"89964_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/nu12020494","author":"K Ishida","year":"2020","unstructured":"Ishida, K. et al. 5-Caffeoylquinic acid ameliorates cognitive decline and reduces A\u03b2 deposition by modulating A\u03b2 clearance pathways in APP\/PS2 transgenic mice. Nutrients https:\/\/doi.org\/10.3390\/nu12020494 (2020).","journal-title":"Nutrients"},{"key":"89964_CR30","doi-asserted-by":"publisher","DOI":"10.1089\/jmf.2013.2881","author":"HR Jeong","year":"2013","unstructured":"Jeong, H. R. et al. Blueberry (Vaccinium virgatum) leaf extracts protect against A\u03b2-induced cytotoxicity and cognitive impairment. J. Med. Food https:\/\/doi.org\/10.1089\/jmf.2013.2881 (2013).","journal-title":"J. Med. Food"},{"key":"89964_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.201800029","author":"DW Lim","year":"2018","unstructured":"Lim, D. W. et al. Chlorogenic acid from Hawthorn berry (Crataegus pinnatifida Fruit) prevents stress hormone-induced depressive behavior, through monoamine oxidase B-reactive oxygen species signaling in hippocampal astrocytes of mice. Mol. Nutr. Food Res. https:\/\/doi.org\/10.1002\/mnfr.201800029 (2018).","journal-title":"Mol. Nutr. Food Res."},{"key":"89964_CR32","doi-asserted-by":"publisher","DOI":"10.2174\/1570159X19666210111155110","author":"XD Chen","year":"2021","unstructured":"Chen, X. D. et al. Chlorogenic acid improves PTSD-like symptoms and associated mechanisms. Curr. Neuropharmacol. https:\/\/doi.org\/10.2174\/1570159X19666210111155110 (2021).","journal-title":"Curr. Neuropharmacol."},{"key":"89964_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsps.2017.04.023","author":"M Miao","year":"2017","unstructured":"Miao, M., Cao, L., Li, R., Fang, X. & Miao, Y. Protective effect of chlorogenic acid on the focal cerebral ischemia reperfusion rat models. Saudi Pharm. J. https:\/\/doi.org\/10.1016\/j.jsps.2017.04.023 (2017).","journal-title":"Saudi Pharm. J."},{"key":"89964_CR34","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-019-01670-x","author":"G Kumar","year":"2019","unstructured":"Kumar, G. et al. Neuroprotective effect of chlorogenic acid in global cerebral ischemia-reperfusion rat model. Naunyn Schmiedebergs Arch. Pharmacol. https:\/\/doi.org\/10.1007\/s00210-019-01670-x (2019).","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"89964_CR35","doi-asserted-by":"publisher","DOI":"10.1111\/ejn.14556","author":"E Hermawati","year":"2020","unstructured":"Hermawati, E., Arfian, N., Mustofa, M. & Partadiredja, G. Chlorogenic acid ameliorates memory loss and hippocampal cell death after transient global ischemia. Eur. J. Neurosci. https:\/\/doi.org\/10.1111\/ejn.14556 (2020).","journal-title":"Eur. J. Neurosci."},{"key":"89964_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25163578","author":"TK Lee","year":"2020","unstructured":"Lee, T. K. et al. Experimental pretreatment with chlorogenic acid prevents transient ischemia-induced cognitive decline and neuronal damage in the hippocampus through anti-oxidative and anti-inflammatory effects. Molecules https:\/\/doi.org\/10.3390\/molecules25163578 (2020).","journal-title":"Molecules"},{"key":"89964_CR37","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2004.02899.x","author":"R Sultana","year":"2005","unstructured":"Sultana, R., Ravagna, A., Mohmmad-Abdul, H., Calabrese, V. & Butterfield, D. A. Ferulic acid ethyl ester protects neurons against amyloid beta-peptide(1\u201342)-induced oxidative stress and neurotoxicity: relationship to antioxidant activity. J. Neurochem. https:\/\/doi.org\/10.1111\/j.1471-4159.2004.02899.x (2005).","journal-title":"J. Neurochem."},{"key":"89964_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2015.08.005","author":"Y Mikami","year":"2015","unstructured":"Mikami, Y. & Yamazawa, T. Chlorogenic acid, a polyphenol in coffee, protects neurons against glutamate neurotoxicity. Life Sci. https:\/\/doi.org\/10.1016\/j.lfs.2015.08.005 (2015).","journal-title":"Life Sci."},{"key":"89964_CR39","doi-asserted-by":"publisher","DOI":"10.1007\/s11064-017-2403-9","author":"O Rebai","year":"2017","unstructured":"Rebai, O. et al. Differential molecular targets for neuroprotective effect of chlorogenic acid and its related compounds against glutamate induced excitotoxicity and oxidative stress in rat cortical neurons. Neurochem. Res. https:\/\/doi.org\/10.1007\/s11064-017-2403-9 (2017).","journal-title":"Neurochem. Res."},{"key":"89964_CR40","doi-asserted-by":"publisher","DOI":"10.1080\/00207454.2019.1702547","author":"M Shi","year":"2020","unstructured":"Shi, M. et al. CGA restrains the apoptosis of A\u03b225-35-induced hippocampal neurons. Int. J. Neurosci. https:\/\/doi.org\/10.1080\/00207454.2019.1702547 (2020).","journal-title":"Int. J. Neurosci."},{"key":"89964_CR41","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-131913","author":"NE Gray","year":"2014","unstructured":"Gray, N. E. et al. Caffeoylquinic acids in Centella asiatica protect against amyloid-\u03b2 toxicity. J. Alzheimers Dis. https:\/\/doi.org\/10.3233\/JAD-131913 (2014).","journal-title":"J. Alzheimers Dis."},{"key":"89964_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/s0014-2999(02)01540-6","author":"T de Paulis","year":"2002","unstructured":"de Paulis, T. et al. Dicinnamoylquinides in roasted coffee inhibit the human adenosine transporter. Eur. J. Pharmacol. https:\/\/doi.org\/10.1016\/s0014-2999(02)01540-6 (2002).","journal-title":"Eur. J. Pharmacol."},{"key":"89964_CR43","doi-asserted-by":"publisher","DOI":"10.1093\/jn\/137.10.2196","author":"M Monteiro","year":"2007","unstructured":"Monteiro, M., Farah, A., Perrone, D., Trugo, L. C. & Donangelo, C. Chlorogenic acid compounds from coffee are differentially absorbed upon and metabolized in humans. J. Nutr. https:\/\/doi.org\/10.1093\/jn\/137.10.2196 (2007).","journal-title":"J. Nutr."},{"key":"89964_CR44","doi-asserted-by":"publisher","DOI":"10.3945\/jn.108.095554","author":"A Farah","year":"2008","unstructured":"Farah, A., Monteiro, M., Donangelo, C. M. & Lafay, S. Chlorogenic acids from green coffee extract are highly bioavailable in humans. J. Nutr. https:\/\/doi.org\/10.3945\/jn.108.095554 (2008).","journal-title":"J. Nutr."},{"key":"89964_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(90)90560-x","author":"JC Fowler","year":"1990","unstructured":"Fowler, J. C. Adenosine antagonists alter the synaptic response to in vitro ischemia in the rat hippocampus. Brain Res. https:\/\/doi.org\/10.1016\/0006-8993(90)90560-x (1990).","journal-title":"Brain Res."},{"key":"89964_CR46","doi-asserted-by":"publisher","DOI":"10.1152\/jn.00813.2018","author":"M Kawamura Jr","year":"2019","unstructured":"Kawamura, M. Jr., Ruskin, D. N. & Masino, S. A. Adenosine A1 receptor-mediated protection of mouse hippocampal synaptic transmission against oxygen and\/or glucose deprivation: a comparative study. J. Neurophysiol. https:\/\/doi.org\/10.1152\/jn.00813.2018 (2019).","journal-title":"J. Neurophysiol."},{"key":"89964_CR47","doi-asserted-by":"publisher","DOI":"10.1097\/FBP.0000000000000076","author":"FDP Fernandes","year":"2014","unstructured":"Fernandes, F. D. P. et al. Caffeic acid protects mice from memory deficits induced by focal cerebral ischemia. Behav. Pharmacol. https:\/\/doi.org\/10.1097\/FBP.0000000000000076 (2014).","journal-title":"Behav. Pharmacol."},{"key":"89964_CR48","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.2001.280.3.R639","author":"LM Gervitz","year":"2001","unstructured":"Gervitz, L. M., Lutherer, L. O., Davies, D. G., Pirch, J. H. & Fowler, J. C. Adenosine induces initial hypoxic-ischemic depression of synaptic transmission in the rat hippocampus in vivo. Am. J. Physiol. https:\/\/doi.org\/10.1152\/ajpregu.2001.280.3.R639 (2001).","journal-title":"Am. J. Physiol."},{"key":"89964_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-018-0110-9","author":"M Temido-Ferreira","year":"2020","unstructured":"Temido-Ferreira, M. et al. Age-related shift in LTD is dependent on neuronal adenosine A2A receptors interplay with mGluR5 and NMDA receptors. Mol. Psychiatry https:\/\/doi.org\/10.1038\/s41380-018-0110-9 (2020).","journal-title":"Mol. Psychiatry"},{"key":"89964_CR50","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1112010","author":"ND Freedman","year":"2012","unstructured":"Freedman, N. D., Park, Y., Abnet, C. C., Hollenbeck, A. R. & Sinha, R. Association of coffee drinking with total and cause-specific mortality. N. Engl. J. Med. https:\/\/doi.org\/10.1056\/NEJMoa1112010 (2012).","journal-title":"N. Engl. J. Med."},{"key":"89964_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jcbfm.9600545","author":"M Xie","year":"2008","unstructured":"Xie, M., Wang, W., Kimelberg, H. K. & Zhou, M. Oxygen and glucose deprivation-induced changes in astrocyte membrane potential and their underlying mechanisms in acute rat hippocampal slices. J. Cereb. Blood Flow Metab. https:\/\/doi.org\/10.1038\/sj.jcbfm.9600545 (2008).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"89964_CR52","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.4518-15.2016","author":"JC O'Donnell","year":"2016","unstructured":"O\u2019Donnell, J. C., Jackson, J. G. & Robinson, M. B. Transient oxygen\/glucose deprivation causes a delayed loss of mitochondria and increases spontaneous calcium signaling in astrocytic processes. J. Neurosci. https:\/\/doi.org\/10.1523\/JNEUROSCI.4518-15.2016 (2016).","journal-title":"J. Neurosci."},{"key":"89964_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2009.06.097","author":"M Montero","year":"2009","unstructured":"Montero, M., Gonz\u00e1lez, B. & Zimmer, J. Immunotoxic depletion of microglia in mouse hippocampal slice cultures enhances ischemia-like neurodegeneration. Brain Res. https:\/\/doi.org\/10.1016\/j.brainres.2009.06.097 (2009).","journal-title":"Brain Res."},{"key":"89964_CR54","doi-asserted-by":"publisher","DOI":"10.1177\/0271678X18805317","author":"Y Fukumoto","year":"2019","unstructured":"Fukumoto, Y. et al. Neuroprotective effects of microglial P2Y1 receptors against ischemic neuronal injury. J. Cereb. Blood Flow Metab. https:\/\/doi.org\/10.1177\/0271678X18805317 (2019).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"89964_CR55","doi-asserted-by":"publisher","DOI":"10.5607\/en.2011.20.4.169","author":"EH Ahn","year":"2011","unstructured":"Ahn, E. H. et al. Chlorogenic acid improves neuroprotective effect of PEP-1-ribosomal protein S3 against ischemic insult. Exp. Neurobiol. https:\/\/doi.org\/10.5607\/en.2011.20.4.169 (2011).","journal-title":"Exp. Neurobiol."},{"key":"89964_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresbull.2012.04.010","author":"W Shen","year":"2012","unstructured":"Shen, W. et al. Chlorogenic acid inhibits LPS-induced microglial activation and improves survival of dopaminergic neurons. Brain Res. Bull. https:\/\/doi.org\/10.1016\/j.brainresbull.2012.04.010 (2012).","journal-title":"Brain Res. Bull."},{"key":"89964_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2014.11.019","author":"R Socodato","year":"2015","unstructured":"Socodato, R. et al. c-Src deactivation by the polyphenol 3-O-caffeoylquinic acid abrogates reactive oxygen species-mediated glutamate release from microglia and neuronal excitotoxicity. Free Radic. Biol. Med. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2014.11.019 (2015).","journal-title":"Free Radic. Biol. Med."},{"key":"89964_CR58","doi-asserted-by":"publisher","DOI":"10.1007\/s12640-018-9911-5","author":"O Rebai","year":"2018","unstructured":"Rebai, O. & Amri, M. Chlorogenic acid prevents AMPA-mediated excitotoxicity in optic nerve oligodendrocytes through a PKC and caspase-dependent pathways. Neurotox. Res. https:\/\/doi.org\/10.1007\/s12640-018-9911-5 (2018).","journal-title":"Neurotox. Res."},{"key":"89964_CR59","doi-asserted-by":"publisher","DOI":"10.1002\/ptr.1652","author":"SS Kim","year":"2005","unstructured":"Kim, S. S., Park, R. Y., Jeon, H. J., Kwon, Y. S. & Chun, W. Neuroprotective effects of 3,5-dicaffeoylquinic acid on hydrogen peroxide-induced cell death in SH-SY5Y cells. Phytother. Res. https:\/\/doi.org\/10.1002\/ptr.1652 (2005).","journal-title":"Phytother. Res."},{"key":"89964_CR60","doi-asserted-by":"publisher","DOI":"10.1080\/09670260500197660","author":"S Pavlica","year":"2005","unstructured":"Pavlica, S. & Gebhardt, R. Protective effects of ellagic and chlorogenic acids against oxidative stress in PC12 cells. Free Radic. Res. https:\/\/doi.org\/10.1080\/09670260500197660 (2005).","journal-title":"Free Radic. Res."},{"key":"89964_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2006.09.017","author":"Y Nakajima","year":"2007","unstructured":"Nakajima, Y., Shimazawa, M., Mishima, S. & Hara, H. Water extract of propolis and its main constituents, caffeoylquinic acid derivatives, exert neuroprotective effects via antioxidant actions. Life Sci. https:\/\/doi.org\/10.1016\/j.lfs.2006.09.017 (2007).","journal-title":"Life Sci."},{"key":"89964_CR62","doi-asserted-by":"publisher","DOI":"10.1017\/S0007114517000587","author":"I Park","year":"2017","unstructured":"Park, I. et al. Effects of subacute ingestion of chlorogenic acids on sleep architecture and energy metabolism through activity of the autonomic nervous system: a randomised, placebo-controlled, double-blinded cross-over trial. Br. J. Nutr. https:\/\/doi.org\/10.1017\/S0007114517000587 (2017).","journal-title":"Br. J. Nutr."},{"key":"89964_CR63","doi-asserted-by":"publisher","DOI":"10.1039\/c8fo01755g","author":"D Cheng","year":"2019","unstructured":"Cheng, D., Li, H., Zhou, J. & Wang, S. Chlorogenic acid relieves lead-induced cognitive impairments and hepato-renal damage via regulating the dysbiosis of the gut microbiota in mice. Food Funct. https:\/\/doi.org\/10.1039\/c8fo01755g (2019).","journal-title":"Food Funct."},{"key":"89964_CR64","doi-asserted-by":"publisher","DOI":"10.1002\/ana.1052","author":"A Ascherio","year":"2001","unstructured":"Ascherio, A. et al. Prospective study of caffeine consumption and risk of Parkinson\u2019s disease in men and women. Ann. Neurol. https:\/\/doi.org\/10.1002\/ana.1052 (2001).","journal-title":"Ann. Neurol."},{"key":"89964_CR65","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000266670.35219.0c","author":"K Ritchie","year":"2007","unstructured":"Ritchie, K. et al. The neuroprotective effects of caffeine: a prospective population study (the Three City Study). Neurology https:\/\/doi.org\/10.1212\/01.wnl.0000266670.35219.0c (2007).","journal-title":"Neurology"},{"key":"89964_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneumeth.2006.12.018","author":"WW Anderson","year":"2007","unstructured":"Anderson, W. W. & Collingridge, G. L. J. Neurosci. Methods. https:\/\/doi.org\/10.1016\/j.jneumeth.2006.12.018 (2007).","journal-title":"J. Neurosci. Methods."},{"key":"89964_CR67","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.14816","author":"SL Reis","year":"2019","unstructured":"Reis, S. L. et al. Adenosine A1 and A2A receptors differently control synaptic plasticity in the mouse dorsal and ventral hippocampus. J. Neurochem. https:\/\/doi.org\/10.1111\/jnc.14816 (2019).","journal-title":"J. Neurochem."},{"key":"89964_CR68","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.3728-09.2009","author":"PM Canas","year":"2009","unstructured":"Canas, P. M. et al. Adenosine A2A receptor blockade prevents synaptotoxicity and memory dysfunction caused by beta-amyloid peptides via p38 mitogen-activated protein kinase pathway. J. Neurosci. https:\/\/doi.org\/10.1523\/JNEUROSCI.3728-09.2009 (2009).","journal-title":"J. Neurosci."},{"key":"89964_CR69","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2011.01299.x","author":"D Van Dam","year":"2011","unstructured":"Van Dam, D. & De Deyn, P. P. Animal models in the drug discovery pipeline for Alzheimer\u2019s disease. Br. J. Pharmacol. https:\/\/doi.org\/10.1111\/j.1476-5381.2011.01299.x (2011).","journal-title":"Br. J. Pharmacol."},{"key":"89964_CR70","doi-asserted-by":"publisher","DOI":"10.3390\/molecules22112007","author":"\u00c1 Kasza","year":"2017","unstructured":"Kasza, \u00c1. et al. Studies for improving a rat model of Alzheimer\u2019s disease: icv administration of well-characterized \u03b2-Amyloid 1\u201342 oligomers induce dysfunction in spatial memory. Molecules https:\/\/doi.org\/10.3390\/molecules22112007 (2017).","journal-title":"Molecules"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-89964-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-89964-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-89964-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T08:34:06Z","timestamp":1670056446000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-89964-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,18]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["89964"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-89964-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,18]]},"assertion":[{"value":"8 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10488"}}